Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners

Investment will enable Surface to fund its development programs focused on FDA approval of its ocular disease drug candidates SAN DIEGO, and PLEASANTON, Calif., May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Surface Pharmaceuticals, Inc., an... Biopharmaceuticals, Ophthalmology, Venture Capital Surface Pharmaceuticals, Imprimis Pharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news